Cleared Traditional

K853835 - EMIT QST CARBAMAZEPINE ASSAY (FDA 510(k) Clearance)

Oct 1985
Decision
15d
Days
Class 2
Risk

K853835 is an FDA 510(k) clearance for the EMIT QST CARBAMAZEPINE ASSAY. This device is classified as a Enzyme Immunoassay, Carbamazepine (Class II - Special Controls, product code KLT).

Submitted by Syva Co. (Palo Alto, US). The FDA issued a Cleared decision on October 1, 1985, 15 days after receiving the submission on September 16, 1985.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3645.

Submission Details

510(k) Number K853835 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1985
Decision Date October 01, 1985
Days to Decision 15 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code KLT — Enzyme Immunoassay, Carbamazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3645